- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 126,920 | 10.07.24 21:18:05 | +0,880 | +0,70% | 126,900 | 126,940 | 125,240 | 126,040 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 96,890 | 10.07.24 21:17:45 | +5,180 | +5,65% | 96,740 | 97,040 | 92,000 | 91,710 |
